Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($) $ in Thousands	Total	Common shares	Treasury Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income / (Loss)	Accumulated Deficit
Balance, beginning of period (in shares) at Jun. 30, 2022		18,247,000
Balance, beginning of period at Jun. 30, 2022	$ 113,459	$ 2	$ (3,406)	$ 197,785	$ (4,562)	$ (76,360)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	6,523					6,523
Foreign currency translation adjustments	(1,677)				(1,677)
Changes in fair value of cash flow hedges	(261)				(261)
Purchase of treasury shares (in shares)		(19,000)
Purchase of treasury shares	(276)		(276)
Provision for common stock warrants	286			286
Issue of common shares related to option issuances (in shares)		2,000
Issuance of common shares	21			21
Stock based compensation expense	806			806
Balance, end of period (in shares) at Sep. 30, 2022		18,230,000
Balance, end of period at Sep. 30, 2022	$ 118,881	$ 2	(3,682)	198,898	(6,500)	(69,837)
Balance, beginning of period (in shares) at Jun. 30, 2023	18,280,419	18,280,000
Balance, beginning of period at Jun. 30, 2023	$ 149,964	$ 2	(3,682)	204,734	(6,312)	(44,778)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	7,425					7,425
Foreign currency translation adjustments	(701)				(701)
Changes in fair value of cash flow hedges	$ (194)				(194)
Purchase of treasury shares (in shares)	(134,524)	(134,000)
Purchase of treasury shares	$ (2,044)		(2,044)
Provision for common stock warrants	287			287
Issue of common shares related to option issuances (in shares)		23,000
Issuance of common shares	5			5
Stock based compensation expense	$ 1,297			1,297
Balance, end of period (in shares) at Sep. 30, 2023	18,169,329	18,169,000
Balance, end of period at Sep. 30, 2023	$ 156,039	$ 2	$ (5,726)	$ 206,323	$ (7,207)	$ (37,353)